324 related articles for article (PubMed ID: 17557320)
1. Intermittent parathyroid hormone (PTH) treatment and age-dependent effects on rat cancellous bone and mineral metabolism.
Friedl G; Turner RT; Evans GL; Dobnig H
J Orthop Res; 2007 Nov; 25(11):1454-64. PubMed ID: 17557320
[TBL] [Abstract][Full Text] [Related]
2. Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1.
Bodine PV; Seestaller-Wehr L; Kharode YP; Bex FJ; Komm BS
J Cell Physiol; 2007 Feb; 210(2):352-7. PubMed ID: 17044082
[TBL] [Abstract][Full Text] [Related]
3. Dose-response effects of intermittent PTH on cancellous bone in hindlimb unloaded rats.
Turner RT; Evans GL; Lotinun S; Lapke PD; Iwaniec UT; Morey-Holton E
J Bone Miner Res; 2007 Jan; 22(1):64-71. PubMed ID: 17042715
[TBL] [Abstract][Full Text] [Related]
4. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW
Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
[TBL] [Abstract][Full Text] [Related]
5. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.
Oxlund H; Ortoft G; Thomsen JS; Danielsen CC; Ejersted C; Andreassen TT
Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210
[TBL] [Abstract][Full Text] [Related]
6. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
[TBL] [Abstract][Full Text] [Related]
7. SOST is a target gene for PTH in bone.
Keller H; Kneissel M
Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
[TBL] [Abstract][Full Text] [Related]
9. Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone.
Pettway GJ; Schneider A; Koh AJ; Widjaja E; Morris MD; Meganck JA; Goldstein SA; McCauley LK
Bone; 2005 Jun; 36(6):959-70. PubMed ID: 15878317
[TBL] [Abstract][Full Text] [Related]
10. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.
Hirano T; Burr DB; Turner CH; Sato M; Cain RL; Hock JM
J Bone Miner Res; 1999 Apr; 14(4):536-45. PubMed ID: 10234574
[TBL] [Abstract][Full Text] [Related]
11. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure.
Compston JE
Bone; 2007 Jun; 40(6):1447-52. PubMed ID: 17045858
[TBL] [Abstract][Full Text] [Related]
12. Effect of intermittent administration of human parathyroid hormone on bone mineral density and arthritis in rats with collagen-induced arthritis.
Fukata S; Hagino H; Okano T; Yamane I; Kameyama Y; Teshima R
Arthritis Rheum; 2004 Dec; 50(12):4060-9. PubMed ID: 15593226
[TBL] [Abstract][Full Text] [Related]
13. Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats.
Nozaka K; Miyakoshi N; Kasukawa Y; Maekawa S; Noguchi H; Shimada Y
Bone; 2008 Jan; 42(1):90-7. PubMed ID: 17997377
[TBL] [Abstract][Full Text] [Related]
14. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing.
Nakazawa T; Nakajima A; Shiomi K; Moriya H; Einhorn TA; Yamazaki M
Bone; 2005 Nov; 37(5):711-9. PubMed ID: 16143574
[TBL] [Abstract][Full Text] [Related]
15. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone.
Hock JM; Gera I
J Bone Miner Res; 1992 Jan; 7(1):65-72. PubMed ID: 1532281
[TBL] [Abstract][Full Text] [Related]
16. Trabecular bone response to mechanical and parathyroid hormone stimulation: the role of mechanical microenvironment.
Kim CH; Takai E; Zhou H; von Stechow D; Müller R; Dempster DW; Guo XE
J Bone Miner Res; 2003 Dec; 18(12):2116-25. PubMed ID: 14672346
[TBL] [Abstract][Full Text] [Related]
17. Effects of parathyroid hormone (1-34) on tibia in an adult rat model for chronic alcohol abuse.
Sibonga JD; Iwaniec UT; Shogren KL; Rosen CJ; Turner RT
Bone; 2007 Apr; 40(4):1013-20. PubMed ID: 17204460
[TBL] [Abstract][Full Text] [Related]
18. Human parathyroid hormone (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats.
Ejersted C; Andreassen TT; Oxlund H; Jørgensen PH; Bak B; Häggblad J; Tørring O; Nilsson MH
J Bone Miner Res; 1993 Sep; 8(9):1097-101. PubMed ID: 8237479
[TBL] [Abstract][Full Text] [Related]
19. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.
McManus JF; Davey RA; Maclean HE; Doust EA; Chiu WS; Sims NA; Bouxsein ML; Glatt V; Zajac JD; Danks JA
Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351
[TBL] [Abstract][Full Text] [Related]
20. Disuse in adult male rats attenuates the bone anabolic response to a therapeutic dose of parathyroid hormone.
Turner RT; Lotinun S; Hefferan TE; Morey-Holton E
J Appl Physiol (1985); 2006 Sep; 101(3):881-6. PubMed ID: 16675609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
